Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, Wanbury has informed that the Trading Window for dealing in securities of Wanbury shall remain closed for the Designated Persons viz. Directors, identified Employees, KMPs, Promoter and Promoter Group of the Company and its subsidiaries including Immediate Relatives of the Designated Persons of the Company and its subsidiaries and for the Connected Persons commencing from 1st January, 2022 till the declaration of Un-audited Financial Results (UFR) of the Company for the quarter and nine months ended 31st December, 2021 and two days thereafter. The date of the Board Meeting of the Company for declaration of Un-audited Financial Results for the quarter and nine months ended 31st December, 2021 will be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |